These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31762153)

  • 1. Effectiveness of brodalumab in acrodermatitis continua of Hallopeau: A case report.
    Passante M; Dastoli S; Nisticò SP; Bennardo L; Patruno C
    Dermatol Ther; 2020 Jan; 33(1):e13170. PubMed ID: 31762153
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of acrodermatitis continua of hallopeau with ixekizumab.
    Miller AC; Holland TE; Cohen DJ
    J Dermatolog Treat; 2021 Feb; 32(1):117-119. PubMed ID: 31184530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ixekizumab for acrodermatitis continua.
    Pilz AC; Roenneberg S; Biedermann T; Eyerich K
    J Dtsch Dermatol Ges; 2018 Jul; 16(7):907-910. PubMed ID: 29927543
    [No Abstract]   [Full Text] [Related]  

  • 4. Acrodermatitis continua of Hallopeau successfully treated with secukinumab.
    Balestri R; Rech G; Tasin L; Rizzoli L; Girardelli CR
    J Dermatolog Treat; 2018; 29(sup1):3-5. PubMed ID: 30246571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau With Brodalumab.
    Milani-Nejad N; Kaffenberger J
    J Drugs Dermatol; 2019 Oct; 18(10):1047. PubMed ID: 31603633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment for acrodermatitis continua of Hallopeau using topical calcipotriol.
    Emtestam L; Wedén U
    Br J Dermatol; 1996 Oct; 135(4):644-6. PubMed ID: 8915165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent and prolonged response to infliximab in a case of recalcitrant acrodermatitis continua of Hallopeau.
    Rubio C; Martin MA; Arranz Sánchez DM; Vidaurrazaga C; Casado M
    J Eur Acad Dermatol Venereol; 2009 Jun; 23(6):707-8. PubMed ID: 18785890
    [No Abstract]   [Full Text] [Related]  

  • 8. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic therapy for acrodermatitis continua of Hallopeau: Successful treatment with secukinumab and review of the literature.
    Galluzzo M; D'Adamio S; Teoli M; Bianchi L; Talamonti M
    Dermatol Ther; 2019 May; 32(3):e12899. PubMed ID: 30969010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of adalimumab for the treatment of refractory paediatric acrodermatitis continua of hallopeau.
    Dini V; Barbanera S; Romanelli M
    Acta Derm Venereol; 2013 Sep; 93(5):588-9. PubMed ID: 23407925
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of acrodermatitis continua of Hallopeau by the tumour necrosis factor-alpha inhibitor infliximab (Remicade).
    Mang R; Ruzicka T; Stege H
    Br J Dermatol; 2004 Feb; 150(2):379-80. PubMed ID: 14996123
    [No Abstract]   [Full Text] [Related]  

  • 12. Acrodermatitis Continua of Hallopeau with Psoriatic Arthritis.
    Khosravi-Hafshejani T; Zhou Y; Dutz JP
    J Rheumatol; 2019 Apr; 46(4):437-438. PubMed ID: 30936225
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical effect of topical calcipotriol in acrodermatitis continua of hallopeau.
    Mozzanica N; Cattaneo A
    Br J Dermatol; 1998 Mar; 138(3):556. PubMed ID: 9580829
    [No Abstract]   [Full Text] [Related]  

  • 14. Brodalumab in the treatment of recalcitrant acrodermatitis continua of Hallopeau.
    Bardazzi F; Di Altobrando A; Lacava R
    Dermatol Ther; 2020 Nov; 33(6):e14301. PubMed ID: 32920959
    [No Abstract]   [Full Text] [Related]  

  • 15. Uselessness of topical calcipotriol as monotherapy for acrodermatitis continua of Hallopeau.
    Kokelj F; Plozzer C; Trevisan G
    Acta Derm Venereol; 2001 May; 81(2):153. PubMed ID: 11501664
    [No Abstract]   [Full Text] [Related]  

  • 16. Adalimumab for a co-existing clinical condition of Crohn's disease and acrodermatitis continua of Hallopeau.
    Caputo F; Parro S; Zoli G
    J Crohns Colitis; 2011 Dec; 5(6):649. PubMed ID: 22115391
    [No Abstract]   [Full Text] [Related]  

  • 17. Ustekinumab for the treatment of acrodermatitis continua of Hallopeau refractory to anti-TNF agents.
    Adışen E; Özer İ; Temel B; Gürer MA
    Dermatol Ther; 2017 Mar; 30(2):. PubMed ID: 28139054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acrodermatitis continua of Hallopeau: evolution of treatment options.
    Sehgal VN; Verma P; Sharma S; Srivastava G; Aggarwal AK; Rasool F; Chatterjee K
    Int J Dermatol; 2011 Oct; 50(10):1195-211. PubMed ID: 21950286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acrodermatitis continua of Hallopeau with adalimumab.
    Ryan C; Collins P; Kirby B; Rogers S
    Br J Dermatol; 2009 Jan; 160(1):203-5. PubMed ID: 18945314
    [No Abstract]   [Full Text] [Related]  

  • 20. Acrodermatitis continua of Hallopeau successfully treated with ixekizumab: A case report.
    Battista T; Guerrasio G; De Fata Salvatores G; Peduto T; Fabbrocini G; Di Guida A
    Dermatol Ther; 2022 May; 35(5):e15383. PubMed ID: 35174591
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.